Higuchi John W. 4
4 · Lipocine Inc. · Filed Dec 17, 2020
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Higuchi John W.
Director
Transactions
- Exercise/Conversion
Common Stock
2020-12-16+3,750→ 700,248 total - Exercise/Conversion
Restricted Stock Unit
2020-12-16+3,750→ 3,750 totalExercise: $0.00From: 2020-12-16Exp: 2027-01-25→ Common Stock (3,750 underlying)
Footnotes (2)
- [F1]Represents shares of Lipocine Inc. common stock ("LPCN Common Stock") acquired upon the vesting of restricted stock units.
- [F2]Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO.